EUVIMEDEUVIMED entdecken
Crossref

Discovery and Advancement of Farnesyl Transferase Inhibitors as Potential Anticancer Therapeutic Agents: SCH 66336 a Case Study

F. Njoroge, Viyyoor Girijavallabhan

Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents · 2001

DOI: 10.2174/1568013013359104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents, 2001. Verfasst von F. Njoroge und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Njoroge, F., & Girijavallabhan, V. (2001). Discovery and Advancement of Farnesyl Transferase Inhibitors as Potential Anticancer Therapeutic Agents: SCH 66336 a Case Study. Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents. https://doi.org/10.2174/1568013013359104

Vancouver

Njoroge F, Girijavallabhan V. Discovery and Advancement of Farnesyl Transferase Inhibitors as Potential Anticancer Therapeutic Agents: SCH 66336 a Case Study. Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents. 2001. doi:10.2174/1568013013359104

BibTeX
@article{Njoroge2001,
  author = {Njoroge, F. and Girijavallabhan, Viyyoor},
  title = {Discovery and Advancement of Farnesyl Transferase Inhibitors as Potential Anticancer Therapeutic Agents: SCH 66336 a Case Study},
  journal = {Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents},
  year = {2001},
  doi = {10.2174/1568013013359104}
}
Kostenlos starten →